Infants with Trisomy 18 and Complex Congenital Heart Defects Should Not Undergo Open Heart Surgery

Abstract

Aggressive medical and surgical interventions have not been clearly demonstrated to improve survival in neonates with trisomy 18; there are no data that demonstrates improved quality of life for these children after these interventions; and these interventions are clearly associated with significant morbidity, resource allocation, and cost.

Get full access to this article

View all access options for this article.

References

H. Y.

Lin ,

S. P.

Lin ,

Y. J.

Chen ,

H. Y.

Hung ,

H. A.

Kao ,

C. H.

Hsu , et al.

“Clinical Characteristics and Survival of Trisomy 18 in a Medical Center in Taipei, 1988-2004,”

American Journal of Medical Genetics Part A 140, no. 9 (2006): 945-951 [hereinafter cited as Lin].

T.K.

Koogler ,

B. S.

Wilfond , and

L. F.

Ross , “Lethal Language, Lethal Decisions,” Hastings Center Report 33, no. 2 (2003): 37-41.

Cereda and

J. C.

Carey , “The Trisomy 18 Syndrome,” Orphanet Journal of Rare Diseases 7 (2012): 81.

B. J.

Baty ,

B. L.

Blackburn , and

J. C.

Carey , “Natural History of Trisomy 18 and Trisomy 13: I. Growth, Physical Assessment, Medical Histories, Survival, and Recurrence Risk,” American Journal of Medical Genetics 49, no. 2 (1994): 175-188 [hereinafter cited as Baty].

B. J.

Baty ,

L. B.

Jorde ,

B. L.

Blackburn , and

J. C.

Carey , “Natural History of Trisomy 18 and Trisomy 13: II. Psychomotor Development,” American Journal of Medical Genetics 49, no. 2 (1994): 189-194 [hereinafter cited as Baty].

Niedrist ,

Riegel ,

Achermann , and

Schinzel , “Survival with Trisomy 18 — Data from Switzerland,” American Journal of Medical Genetics Part A 140, no. 9 (2006): 952-959 [hereinafter cited as Niedrist]; see Lin et al., supra note 1, at 947-949.

Maeda ,

Yamagishi ,

Furutani ,

Kamisago ,

Waragai ,

Oana , et al.

“The Impact of Cardiac Surgery in Patients with Trisomy 18 and Trisomy 13 in Japan,”

American Journal of Medical Genetics Part A 155A (11) (2011): 2641-2646 [hereinafter cited as Maeda];

N. D.

Embleton ,

J. P.

Wyllie ,

M. J.

Wright ,

Burn , and

Hunter , “Natural History of Trisomy 18,” ADC Fetal Neonatal Edition 75, no. 1 (1996): F38-F41 [hereinafter cited as Embleton]; see Lin et al., supra note 1, at 948-949.

Root and

J. C.

Carey , “Survival in Trisomy 18,” American Journal of Medical Genetics 49, no. 2 (1994): 170-174;

S. A.

Rasmussen ,

L. Y.

Wong ,

Yang ,

K. M.

May , and

J. M.

Friedman , “Population-Based Analyses of Mortality in Trisomy 13 and Trisomy 18,” Pediatrics 111, no. 4, pt. 1 (2003):777-84;

S. E.

Parker ,

C. T.

Mai ,

M. A.

Canfield ,

Rickard ,

Wang ,

R. E.

Meyer et al., “Updated National Birth Prevalence Estimates for Selected Birth Defects in the United States, 2004-2006,” Birth Defects Research Part A: Clinical and Molecular Teratology 88, no. 12 (2010): 1008-1016;

Wu ,

Springett , and

J. K.

Morris , “Survival of Trisomy 18 (Edwards Syndrome) and Trisomy 13 (Patau Syndrome) in England and Wales: 2004-2011,” American Journal of Medical Genetics Part A 161, no. 10 (2013): 2512-8 [hereinafter cited as Wu]; see Lin et al., supra note 1, at 946-947; Niedrist et al., supra note 6, at 953-955; Embleton, supra note 7, at F39.

See Wu et al., supra note 8, at 2512.

10.

See Baty et al., supra note 4, at 175.

11.

Id., at 175.

12.

See Baty, supra note 5, at 189.

13.

Id., at 189.

14.

Niermeyer ,

Kattwinkel ,

R. P.

Van ,

Nadkarni ,

Phillips , and

Zideman , et al.

“International Guidelines for Neonatal Resuscitation: An Excerpt from the Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: International Consensus on Science. Contributors and Reviewers for the Neonatal Resuscitation Guidelines,”

Pediatrics 106, no. 3 (2000): E29.

15.

“The International Liaison Committee on Resuscitation (ILCOR) Consensus on Science with Treatment Recommendations for Pediatric and Neonatal Patients: Neonatal Resuscitation,”

Pediatrics 117, no. 5 (2006): e978-e988.

16.

Kattwinkel ,

J. M.

Perlman ,

Aziz ,

Colby ,

Fairchild , and

Gallagher et al., “Neonatal Resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,” Pediatrics 126, no. 5 (2010): e1400-e1413.

17.

M. P.

McGraw and

J. M.

Perlman , “Attitudes of Neonatologists toward Delivery Room Management of Confirmed Trisomy 18: Potential Factors Influencing a Changing Dynamic,” Pediatrics 121, no. 6 (2008): 1106-10 [hereinafter cited as McGraw].

18.

See McGraw, supra note 17, at 1106.

19.

Kosho ,

Nakamura ,

Kawame ,

Baba ,

Tamura , and

Fukushima , “Neonatal Management of Trisomy 18: Clinical Details of 24 Patients Receiving Intensive Treatment,” American Journal of Medical Genetics Part A 140, no. 9 (2006): 937-44 [hereinafter cited as Kosho].

20.

See Kosho, supra note 19, at 942.

21.

Goc ,

Walencka ,

Wloch ,

Wojciechowska ,

Wiecek-Wlodarska , and

Krzystolik-Ladzinska et al., “Trisomy 18 in Neonates: Prenatal Diagnosis, Clinical Features, Therapeutic Dilemmas and Outcome,” Journal of Applied Genetics 47, no. 2 (2006): 165-70 [hereinafter cited as Goc].

22.

See Goc, supra note 21, at 169-170.

23.

Dyer

, “Parents Fail to Overturn Ruling Not to Resuscitate Baby,” British Medical Journal 330, no 7498 (2005): 985;

Dyer

, “Doctors Need Not Ventilate Baby to Prolong his Life,” British Medical Journal 329, no. 7473 (2004): 995.

24.

See Embleton, supra note 7, at F39-F41.

25.

See Embleton, supra note 7, at F39-F41; Wu, supra note 8, at 2512.

26.

See Baty, supra note 4, at 175.

27.

Khairy ,

Ionescu-Ittu ,

A. S.

Mackie ,

Abrahamowicz ,

Pilote , and

A. J.

Marelli , “Changing Mortality in Congenital Heart Disease,” Journal of the American College of Cardiology 56, no. 14 (2010): 1149-57.

28.

E. M.

Graham ,

S. M.

Bradley ,

G. S.

Shirali ,

C. B.

Hills , and

A. M.

Atz , “Effectiveness of Cardiac Surgery in Trisomies 13 and 18 (from the Pediatric Cardiac Care Consortium),” American Journal of Cardiology 93, no. 6 (2004): 801-3 [hereinafter cited as Graham].

29.

See Graham, supra note 28, at 802.

30.

Kaneko ,

Kobayashi ,

Yamamoto ,

Yoda ,

Kanetaka , and

Nakajima , et al.

“Intensive Cardiac Management in Patients with Trisomy 13 or Trisomy 18,”

American Journal of Medical Genetics Part A 146A, no. 11 (2008): 1372-80 [hereinafter cited as Kaneko].

31.

Id., at 1375-1378.

32.

Muneuchi ,

Yamamoto ,

Takahashi ,

Watanabe ,

Yuge , and

Ohno et al., “Outcomes of Cardiac Surgery in Trisomy 18 patients,” Cardiology in the Young 21, no. 2 (2011): 209-15 [hereinafter cited as Muneuchi].

33.

Id., at 211-213.

34.

Kaneko ,

Kobayashi ,

Achiwa ,

Yoda ,

Tsuchiya , and

Nakajima , et al., “Cardiac Surgery in Patients with Trisomy 18,” Pediatric Cardiology 30, no. 6 (2009): 729-34 [hereinafter cited as Kaneko].

35.

See Kaneko, supra note 34, at 733.

36.

See Maeda, supra note 7, at 2641.

37.

M. H.

Ma ,

He , and

O. J.

Benavidez , “Congenital Heart Surgical Outcomes in Patients with Trisomy 13 and 18,” Circulation 128, no. 22 (2013): A17120.

38.

Janvier ,

Okah ,

Farlow , and

J. D.

Lantos , “An Infant with Trisomy 18 and a Ventricular Septal Defect,” Pediatrics 127, no. 4 (2011): 754-9.

39.

Kumar

, “Care of an Infant with Lethal Malformation: Where Do We Draw the Line?” Pediatrics 128, no. 6 (2011): e1642-e1643;

J. J.

Paris ,

A. H.

Weiss , and

Soifer , “Ethical Issues in the Use of Life-Prolonging Interventions for an Infant with Trisomy 18,” Journal of Perinatology 12, no. 4 (1992): 366-8; see McGraw and Perlman, supra note 17, at 1108-1109.